ELIXIR (ELIXIR) Fair Value & Analysis

IN · Market cap ₹703M

E ELIXIR ELIXIR · BSE

Price₹120.95

Fair Value₹104.35

Upside-13.7%

Quality48/100

Watch ELIXIR for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range ₹76.70 – ₹130.44

Fair value as of: Jul 5, 2026

From 24 valuation models · updated today

Share price +9.8% over the past month.

Price vs Fair Value (12 months)

12‑month range ₹79.35 – ₹137.10 · fair‑value band ₹76.70 – ₹130.44 · the ₹120.95 price screens above the ₹104.35 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

ELIXIR (ELIXIR) currently trades at ₹120.95, while our model-based Fair Value estimate is ₹104.35 — implying the stock looks roughly 13.7% overvalued today. We read business quality at 48/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, ELIXIR generated revenue of ₹337M at a net margin of 9.0%. Revenue grew 134.4% year over year. It earns a return on equity of 5.0%. Net debt stands at ₹216M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹76.70 (bear case) to ₹130.44 (bull case); at ₹120.95, the current price sits within that range. The share trades about 16% below its 52-week high and 55% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹337M

Revenue growth (YoY) +134%

Net margin 9.0%

Return on equity 5.0%

Free cash flow ₹27.1M FY2026

P/E ratio 23.1

More key figures

Operating margin 1,091%

EPS (TTM) ₹5.23

Dividend yield 1.0%

EPS growth (YoY) +357%

Net debt ₹216M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

ELIXIR reported revenue of ₹337M in FY2026 versus ₹242M in FY2022, a compound +8.7%/yr. Reported net income was ₹30.3M in FY2026, compounding −25.0%/yr from FY2022.

Revenue +8.7%/yr

FY22 ₹242M

FY23 ₹30.5M

FY24 ₹320M

FY25 ₹354M

FY26 ₹337M

Net income −25.0%/yr

FY22 ₹96.0M

FY23 −₹34.3M

FY24 ₹210M

FY25 ₹126M

FY26 ₹30.3M

Is ELIXIR fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

📤 Share or link this analysis

𝕏 Post WhatsApp LinkedIn Reddit

🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

ELIXIR · Fair Value
₹104.35 −14%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/ELIXIR" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">ELIXIR · Fair Value</span><br><b style="font-size:20px">₹104.35</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−14%</span></span><span style="font-size:11px;color:#7BB290;font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "ELIXIR Fair Value". https://www.fairvalue-calculator.com/stock/ELIXIR

Explore undervalued stocks

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is ELIXIR (ELIXIR) undervalued?

As of Jul 5, 2026, our model estimates a fair value of ₹104.35 versus a price of ₹120.95 — about −14% (overvalued). Model-based estimate, not financial advice.

What is the fair value of ELIXIR?

Our model-based fair value for ELIXIR is ₹104.35 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹120.95.

What is the quality score of ELIXIR?

ELIXIR has a Quality Score of 48/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of ELIXIR (ELIXIR)?

ELIXIR reported trailing-twelve-month revenue of about ₹337M (latest available figure, as of Jul 5, 2026).

What is the net profit margin of ELIXIR?

The net profit margin of ELIXIR is about 9.0%, meaning it keeps roughly 9.0% of revenue as net income. Based on the latest reported figures.

Does ELIXIR pay a dividend?

ELIXIR currently shows a dividend yield of about 1.03% relative to its recent price (as of Jul 5, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.